Eevia Health Plc receives a 171 kSEK / 15 kEUR sales order for a Chaga extract

Eevia Health Plc ("Eevia" or "The Company") has received an 11 KEUR sales order for Feno-Chaga®  Organic from a nutraceutical brand in the USA.

The indirect customer is a brand owner in the USA and the order came via one of Eevia's distributors in North America. It is a fast-growing brand owner of dietary supplements.

The sales value to Eevia of this new order is c. KEUR 11. The product FENO-CHAGA™ ORGANIC, which is a standardized chaga mushroom extract in powder form, which has documented immunomodulating effects. It is standardized on beta-glucans and polyphenols. The product is made from wild-harvested chaga from Finland, a mushroom (strictly speaking a fungi), growing naturally on birch trees.

The order is expected to be followed by further repeat orders in the future. Mushrooms is a fast-growing supplements category in North America.

For further information, please contact:

Stein Ulve, CEO, Eevia Health Plc                          

Email: [email protected]                      

Telephone: +358 400 22 5967    


Eevia Health Plc, founded in March 2017, addresses significant health problems with bioactive compounds extracted from plant materials. The materials are primarily wild harvested from the pristine Finnish and Swedish forests near or above the Arctic Circle. The extracts are sold B2B as ingredients in dietary supplements and food brands globally. These global brands utilize the ingredients in their consumer product formulas.

Eevia Health is a manufacturer of 100% organically certified plant extracts. Although a significant product, Elderberry extract, is made from cultivated berries, most of Eevia's other raw materials, such as bilberry, lingonberry, chaga-mushroom, and pine bark, are wild-harvested in a sustainable fashion.

Eevia Health operates a modern green-chemistry production facility in Finland. Manufacturing natural ingredients near the raw material harvest areas, Eevia offers a short value chain with an environmentally friendly carbon footprint, competitive pricing, and extreme transparency. Eevia listed its shares at Spotlight Stock Market in Sweden in June 2021, with the short name (ticker) EEVIA.

To learn more, please visit or follow Eevia Health on LinkedIn@EeviaHealth. 

Om Eevia Health

Eevia Health targets health problems with bioactive extracts from plant material. The human body has an incredible ability to restore good health. However, sometimes the body needs active support. Our mission is to support good health and well-being with plant extracts which have scientifically documented health benefits. Eevia Health manufactures and markets organic ingredients from abundant plant material in the Arctic. Our products are targeted against low-grade inflammation, problems in eye and brain health, and metabolic effects. We collaborate with scientists in Finland and abroad to scientifically substantiate the positive effects of ingredients and also to document the safety of use.



Kurs ()
Förändring ()
Marknad Spotlight stock market Kortnamn EEVIA ISIN-kod FI4000496658


Stein Ulve IR-kontakt [email protected]